1-4 of 4
Dimitri Breems, MD
Close
Sort by
Journal Articles

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study

A. W. Rijneveld, Bronno van der Holt, Okke de Weerdt, MD, Bart J. Biemond, MD PhD, Arjen van de Loosdrecht, Eefke Petersen, MD, Mar Bellido, Harry C. Schouten, MD, Walter J F M van der Velden, Dominik Selleslag, Martin R. Schipperus, Constantijn J.M. Halkes, Saskia Klein, MD, Violaine Havelange, Marinus van Marwijk Kooij, MD PhD, Marie-Cecile Legdeur, Jeannine Refos, Vincent van der Velden, PhD, Jan J Cornelissen, Crista Homburg, Valerie de Haas, MD PhD, Dries Deeren, MD, Alain Gaddiseur, Harm Sinnige, Dimitri Breems, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2606.
https://doi.org/10.1182/blood.V130.Suppl_1.2606.2606
Published: 2017
Journal Articles

Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (≥ 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)

Geert Huls, MD PhD, Dana Chitu, Violaine Havelange, Mojca Jongen-Lavrencic, MD PhD, Arjen van de Loosdrecht, Bart J. Biemond, MD PhD, Harm Sinnege, MDPhD, Beata Hodossy, Carlos Graux, Marinus van Marwijk Kooij, MD PhD, Okke de Weerdt, MD, Dimitri Breems, MD PhD, Saskia Klein, MD, Jurgen Kuball, MD, Gert J. Ossenkoppele, MD PhD, Bob Lowenberg, MD PhD, Edo Vellenga, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 463.
https://doi.org/10.1182/blood.V130.Suppl_1.463.463
Published: 2017
Journal Articles

CHR-2845, a Monocyte/Macrophage Targeted Histone Deacetylase Inhibitor In a First In Man Clinical Trial In Subjects with Advanced Haematological Malignancies

Gert Ossenkoppele, MD, PhD, Bob Lowenberg, MD, PhD, Pierre Zachee, MD, PhD, Norbert Vey, Dimitri Breems, MD, PhD, Arjan A. Van de Loosdrecht, MD, PhD, Phillip Debnam, PhD, Lindsey Needham, PhD, Lindsay Bawden, PhD, Leon Hooftman, MD
Journal: Blood
Blood (2010) 116 (21): 3279.
https://doi.org/10.1182/blood.V116.21.3279.3279
Published: 2010
Journal Articles

A Phase I Study of CHR-2797, an Orally Active Aminopeptidase Inhibitor in Elderly and/or Treatment Refractory Patients with Acute Myeloid Leukemia or Multiple Myeloma.

Faith Davies, MD, Gert Ossenkoppele, MD, Pierre Zachee, MD, Richard Noppeney, MD, Alan Burnett, MD, Michel Delforge, MD, Pieter Sonneveld, MD, Gareth Morgan, MD, Sonja Zweegman, MD, Dimitri Breems, MD, Alison Richardson, PhD, Leon Hooftman, MD, Bob Lowenberg, MD
Journal: Blood
Blood (2007) 110 (11): 443.
https://doi.org/10.1182/blood.V110.11.443.443
Published: 2007